Abstract
D15 - Patients with borderline resectable colorectal cancer liver metastases (CLM): preliminary safety and activity of perioperative triplet chemotherapy plus bevacizumab (bev)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
